Qing Yang
1
PUBLICATIONS
0
CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Get your video featured.
Publish with JoVE
Get your video featured.
Publish with JoVE
Publications
(1)
Sort by Publication Date:
Latest
BMC gastroenterology
|
Oct 09, 2026
Cost-effectiveness analysis of durvalumab combined with tremelimumab versus sorafenib as first-line treatment for unresectable Hepatocellular carcinoma in China: a dual-model approach utilizing partitioned survival and markov models.
Page
of 1
Frequent Collaborators
Frequent Collaborators
See all collaborators
Search research articles
Contact Us